Clik here to view.
Propanc Biopharma Receives First Allowance for Key Patent Family from...
MELBOURNE, Australia Propanc Biopharma, Inc. (OTC:PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing new cancer treatments for patients suffering from recurring and...
View ArticleClik here to view.
Hansoh Expands AI Partnership with Atomwise after Early Success for Key...
SHANGHAI & SAN FRANCISCO Hansoh Pharma (3692:HK), a leading biopharmaceutical company in China, and Atomwise, the leader in artificial intelligence (AI) for drug discovery, today announced the...
View ArticleClik here to view.
Biolytic推出Dr. Oligo 768XLc DNA RNA合成仪——合成768 Oligos变得更快
加州弗里蒙特 (美国商业资讯)–Biolytic Lab Performance Inc.推出其新型寡核苷酸合成仪Dr. Oligo 768XLc，这是用于高通量核酸合成的最先进的商业平台。该合成仪旨在用于研发和生产设施，满足那些专注于各种病毒、疾病和病况诊断和治疗应用的组织的需求，在这些组织中，大量独特的DNA和RNA对他们的产品、服务和进行中的研究至关重要。...
View ArticleClik here to view.
Samsung Bioepis Announces US Launch of ONTRUZANT® (trastuzumab-dttb) for...
INCHEON, Korea Samsung Bioepis Co., Ltd. announced today that ONTRUZANT® (trastuzumab-dttb), a biosimilar of the reference biologic medicine HERCEPTIN®1 (trastuzumab) for the treatment of...
View ArticleClik here to view.
バイオリティックが768本のオリゴヌクレオチド合成を迅速化するDNA／RNA合成装置のDr. Oligo 768XLcを発表
米カリフォルニア州フリーモント （ビジネスワイヤ） — バイオリティック・ラボ・パフォーマンスは新規オリゴヌクレオチド合成装置のDr. Oligo...
View ArticleClik here to view.
Singapore Researchers Use NanoString’s nCounter Platform to Rapidly Profile...
SEATTLE NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced the first publication utilizing the nCounter®...
View ArticleClik here to view.
How Propanc Biopharma Is Joining the Fight with Cancer Patients Who Are...
MELBOURNE, Australia Propanc Biopharma, Inc. (OTC: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing new cancer treatments for patients suffering from recurring and...
View ArticleClik here to view.
LegoChem Biosciences and Iksuda Enter into a Multi-Target Research...
DAEJEON, South Korea LegoChem Biosciences, Inc. (“LCB”) (KOSDAQ:141080), based in Daejeon, South Korea, announced today that it has entered a research collaboration and license agreement with Iksuda...
View ArticleClik here to view.
Promega Successfully Completes First Fully Remote Quality Surveillance...
MADISON, Wis. Promega Corporation announced today it successfully completed its first ever fully remote quality surveillance assessment and is recommended for continued certification to ISO...
View ArticleClik here to view.
Genetron Health Announces Forthcoming Unveiling of Its Cancer Research Papers...
BEIJING Genetron Holdings Limited (“Genetron Health”), a China-based precision oncology company that covers full-cycle cancer care, announced that 14 cancer research papers will be presented as...
View ArticleAVITA Medical Announces Intention to Redomicile to the United States of America
VALENCIA, Calif. & MELBOURNE, Australia AVITA Medical Limited (Company) (ASX: AVH, NASDAQ: RCEL), a regenerative medicine company with a technology platform positioned to address unmet medical...
View ArticleClik here to view.
Gilead, Kite and oNKo-innate Announce Research Collaboration to Discover...
FOSTER CITY, Calif. & SANTA MONICA, Calif. & MELBOURNE, Australia Gilead Sciences, Inc. (Nasdaq: GILD), Kite, a Gilead Company, and oNKo-innate announced the companies have entered into a...
View ArticleClik here to view.
NEC Publishes Design Blueprints for SARS-CoV-2 Vaccines Using Its Artificial...
TOKYO NEC Corporation (NEC; TOKYO: 6701) today announced analysis results from efforts using AI prediction platforms to design blueprints for SARS-CoV-2 vaccines that can drive potent T-cell...
View ArticleClik here to view.
EpimAb Biotherapeutics and QIMR Berghofer Medical Research Institute Announce...
SHANGHAI & BRISBANE, Australia EpimAb Biotherapeutics, an emerging Shanghai-based biopharmaceutical company specializing in bispecific antibodies, and the QIMR Berghofer Medical Research...
View ArticleClik here to view.
Topcon Singapore Medical Announces its New Managing Director
SINGAPORE Topcon Singapore Medical Pte. Ltd. (“TSM”) has announced that Leo Hiroshi Nagatake, who is currently leading Topcon Healthcare Solutions Asia Pacific (”THSAP”), has been appointed as TSM’s...
View ArticleClik here to view.
NEC发布采用其人工智能技术的SARS-CoV-2疫苗设计蓝图
东京 (美国商业资讯)–NEC Corporation (NEC; TOKYO: 6701)今天发布采用AI预测平台设计SARS-CoV-2疫苗蓝图的分析结果，该疫苗能在全球多数人群中推动强效T细胞应答。NEC集团科学团队发起的这项创举旨在帮助抗击COVID-19疫情并支持国际疫苗开发努力，由NEC OncoImmununity (NOI)与NEC Laboratories Europe...
View ArticleClik here to view.
Takeda Continues Divestiture Strategy with Sale of Select OTC and Non-Core...
OSAKA, Japan Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that it has entered into an agreement to divest a portfolio of select non-core over-the-counter...
View ArticleClik here to view.
Takeda Announces U.S. FDA Breakthrough Therapy Designation for Mobocertinib...
CAMBRIDGE, Mass. & OSAKA, Japan Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that the U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy...
View ArticleClik here to view.
BioDuro & neoX Partner to Create Next Generation Antibody Discovery Platform
SAN DIEGO & BEIJING BioDuro, LLC, a leading drug discovery and development services organization, and neoX, a leading-edge artificial intelligence and biophysics focused biotech, announced today...
View ArticleAVITA Medical Reports Third Quarter Fiscal 2020 Financial Results and Company...
VALENCIA, Calif. & MELBOURNE, Australia AVITA Medical Limited (ASX: AVH, NASDAQ: RCEL), a regenerative medicine company with a technology platform positioned to address unmet medical needs in...
View Article